Perceptions diverge on aspects related to substance use disorder: An analysis of individuals in recovery, physicians, nurses, and medical students

References

• Soyka M, Gorelick DA. Why should addiction medicine be an attractive field for young physicians? Addiction. 2009;104(2):169–172.
   PubMed Web of Science ®Google Scholar
• Mental Health and Substance Use Disorders Substance Abuse and Mental Health Services Administration. 2020. https://www.samhsa.gov/find-help/disorders. Accessed April 4, 2020.
   Google Scholar
• Vogel EA, Ly K, Ramo DE, Satterfield J. Strategies to improve treatment utilization for substance use disorders: a systematic review of intervention studies. Drug Alcohol Depend. 2020;212:108065.
   PubMed Web of Science ®Google Scholar
• Thylstrup B, Seid AK, Tjagvad C, Hesse M. Incidence and predictors of drug overdoses among a cohort of >10,000 patients treated for substance use disorder. Drug Alcohol Depend. 2020;206:107714.
   PubMed Web of Science ®Google Scholar
• Hinde JM, Mark TL, Fuller L, Dey J, Hayes J. Increasing access to opioid use disorder treatment: assessing state policies and the evidence behind them. J Stud Alcohol Drugs. 2019;80(6):693–697.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Han BH, Keyes KM. Trends in characteristics of individuals who use methamphetamine in the United States, 2015–2018. Drug Alcohol Depend. 2020;213:108089.
   PubMed Web of Science ®Google Scholar
• Chan B, Freeman M, Kondo K, et al. Pharmacotherapy for methamphetamine/amphetamine use disorder-a systematic review and meta-analysis. Addiction. 2019;114(12):2122–2136.
   PubMed Web of Science ®Google Scholar
• McCradden MD, Vasileva D, Orchanian-Cheff A, Buchman DZ. Ambiguous identities of drugs and people: a scoping review of opioid-related stigma. Int J Drug Policy. 2019;74:205–215.
   PubMed Web of Science ®Google Scholar
• Lanzillotta-Rangeley J, Leslie J, Little M, Stem J, Asselin E, Kurahovic M. Educational program to increase substance use disorder knowledge and decrease stigma in first-year nursing students. Pain Manag Nurs. 2020;2020:123–142.
   Google Scholar
• van Boekel LC, Brouwers EP, van Weeghel J, Garretsen HF. Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review. Drug Alcohol Depend. 2013;131(1–2):23–35.
   PubMed Web of Science ®Google Scholar
• Kennedy-Hendricks A, Busch SH, McGinty EE, et al. Primary care physicians’ perspectives on the prescription opioid epidemic. Drug Alcohol Depend. 2016;165:61–70.
   PubMed Web of Science ®Google Scholar
• Cooke AC, Knight KR, Miaskowski C. Patients’and clinicians’perspectives of co-use of cannabis and opioids for chronic non-cancer pain management in primary care. Int J Drug Policy. 2019;63:23–28.
   PubMed Web of Science ®Google Scholar
• Penm J, MacKinnon NJ, Lyons MS, Tolle E, Sneed GT. Combatting opioid overdoses in Ohio: emergency department physicians’ prescribing patterns and perceptions of naloxone. J Gen Intern Med. 2018;33(5):608–609.
   PubMed Web of Science ®Google Scholar
• Horner G, Daddona J, Burke DJ, Cullinane J, Skeer M, Wurcel AG. “You’re kind of at war with yourself as a nurse”: perspectives of inpatient nurses on treating people who present with a comorbid opioid use disorder. PLoS One. 2019;14(10):e0224335.
   PubMed Web of Science ®Google Scholar
• Taha S, Maloney-Hall B, Buxton J. Lessons learned from the opioid crisis across the pillars of the Canadian drugs and substances strategy. Subst Abuse Treat Prev Policy. 2019;14(1):32.
   PubMed Web of Science ®Google Scholar
• Delacre M, Leys C, Mora Y, Lakens D. Taking parametric assumptions seriously: arguments for the use of Welch’s F-test instead of the Classical F-test in One-way ANOVA. Internat Rev Soc Psychol. 2019;32.
   Google Scholar
• Tomarken AJ, Serlin RC. Comparison of ANOVA alternatives under variance heterogeneity and specific noncentrality structures. Psychological Bulletin. 1986;99(1):90–99.
   Web of Science ®Google Scholar
• Nielsen S, Sanfilippo P, Belackova V, et al. Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities. Addiction. 2020. doi:https://doi.org/10.1111/add.15297
   Google Scholar
• Bjornestad J, Svendsen TS, Slyngstad TE, et al. “A life more ordinary” processes of 5-year recovery from substance abuse. Experiences of 30 recovered service users. Front Psychiatry. 2019;10:689.
   PubMed Web of Science ®Google Scholar
• Cadet JL. Epigenetics of stress, addiction, and resilience: therapeutic implications. Mol Neurobiol. 2016;53(1):545–560.
   PubMed Web of Science ®Google Scholar
• Cioe K, Biondi BE, Easly R, Simard A, Zheng X, Springer SA. A systematic review of patients’ and providers’ perspectives of medications for treatment of opioid use disorder. J Subst Abuse Treat. 2020;119:108146.
   PubMed Web of Science ®Google Scholar
• Friedrichs A, Spies M, Härter M, Buchholz A. Patient preferences and shared decision making in the treatment of substance use disorders: a systematic review of the literature. PLoS One. 2016;11(1):e0145817.
   PubMed Web of Science ®Google Scholar
• Fiorentin TR, Logan BK. Analytical findings in used syringes from a syringe exchange program. Int J Drug Policy. 2020;81:102770.
   PubMed Web of Science ®Google Scholar
• Yang YT, Beletsky L. United States vs Safehouse: the implications of the Philadelphia supervised consumption facility ruling for law and social stigma. Prev Med. 2020;135:106070.
   PubMed Web of Science ®Google Scholar
• McGinty EE, Barry CL, Stone EM, et al. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018;111:73–77.
   PubMed Web of Science ®Google Scholar
• Green TC, Davis C, Xuan Z, Walley AY, Bratberg J. Laws mandating coprescription of naloxone and their impact on naloxone prescription in five US States, 2014–2018. Am J Public Health. 2020;110(6):881–887.
   PubMed Web of Science ®Google Scholar
• Ingram I, Kelly PJ, Deane FP, et al. Loneliness among people with substance use problems: a narrative systematic review. Drug Alcohol Rev. 2020;39(5):447–483.
   PubMed Web of Science ®Google Scholar
• Moeller SJ, Platt JM, Wu M, Goodwin RD. Perception of treatment need among adults with substance use disorders: longitudinal data from a representative sample of adults in the United States. Drug Alcohol Depend. 2020;209:107895.
   PubMed Web of Science ®Google Scholar
• Richards JR, Hawkins JA, Acevedo EW, Laurin EG. The care of patients using methamphetamine in the emergency department: perception of nurses, residents, and faculty. Subst Abus. 2019;40(1):95–101.
   PubMed Web of Science ®Google Scholar
• Shearer RD, Howell BA, Bart G, Winkelman TNA. Substance use patterns and health profiles among US adults who use opioids, methamphetamine, or both, 2015–2018. Drug Alcohol Depend. 2020;214:108162.
   PubMed Web of Science ®Google Scholar
• Miles J, Howell J, Sheridan D, Braucht G, Mericle A. Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic. Am J Drug Alcohol Abuse. 2020;46(3):266–272.
   PubMed Web of Science ®Google Scholar
• Bech AB, Clausen T, Waal H, et al. Post-mortem toxicological analyses of blood samples from 107 patients receiving opioid agonist treatment: substances detected and pooled opioid and benzodiazepine concentrations. Addiction. 2020. doi:https://doi.org/10.1111/add.15211
   Google Scholar
• Abram MD. The role of the registered nurse working in substance use disorder treatment: a hermeneutic study. Issues Ment Health Nurs. 2018;39(6):490–498.
   PubMed Web of Science ®Google Scholar
• Smothers Z, Reynolds V, McEachern M, Derouin AL, Carter BM, Muzyk A. Substance use education in schools of nursing: a systematic review of the literature. Nurse Educ. 2018;43(3):136–139.
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain – United States, 2016. MMWR Recomm Rep. 2016;65(1):1–49.
   PubMed Web of Science ®Google Scholar
• Shreffler J, Shaw I, Berrones A, Huecker M. Prescription history before opioid overdose death: PDMP data and responsible prescribing. J Public Health Manag Pract. 2020. doi:https://doi.org/10.1097/PHH.0000000000001210
   Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016;315(15):1624–1645.
   PubMed Web of Science ®Google Scholar